Fiduciary Trust Co. Reduces Position in Aetna Inc (AET)

Fiduciary Trust Co. lessened its holdings in shares of Aetna Inc (NYSE:AET) by 2.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,349 shares of the company’s stock after selling 280 shares during the period. Fiduciary Trust Co.’s holdings in Aetna were worth $2,266,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Bessemer Group Inc. grew its stake in shares of Aetna by 4.2% in the 2nd quarter. Bessemer Group Inc. now owns 7,854 shares of the company’s stock valued at $1,441,000 after buying an additional 315 shares during the period. Sumitomo Mitsui Asset Management Company LTD grew its stake in shares of Aetna by 1.4% in the 2nd quarter. Sumitomo Mitsui Asset Management Company LTD now owns 23,062 shares of the company’s stock valued at $4,231,000 after buying an additional 319 shares during the period. Harvest Fund Management Co. Ltd grew its stake in shares of Aetna by 34.1% in the 2nd quarter. Harvest Fund Management Co. Ltd now owns 1,341 shares of the company’s stock valued at $246,000 after buying an additional 341 shares during the period. Johnson Financial Group Inc. grew its stake in shares of Aetna by 3.1% in the 1st quarter. Johnson Financial Group Inc. now owns 11,572 shares of the company’s stock valued at $1,956,000 after buying an additional 353 shares during the period. Finally, Canandaigua National Bank & Trust Co. grew its stake in shares of Aetna by 3.7% in the 2nd quarter. Canandaigua National Bank & Trust Co. now owns 10,334 shares of the company’s stock valued at $1,896,000 after buying an additional 368 shares during the period. 85.40% of the stock is owned by institutional investors.

Shares of Aetna opened at $193.78 on Friday, Marketbeat.com reports. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.44. Aetna Inc has a one year low of $149.69 and a one year high of $194.88. The company has a market capitalization of $61.61 billion, a PE ratio of 18.24, a P/E/G ratio of 1.59 and a beta of 0.67.



Aetna (NYSE:AET) last issued its quarterly earnings data on Thursday, August 2nd. The company reported $3.43 EPS for the quarter, topping the consensus estimate of $3.04 by $0.39. Aetna had a net margin of 5.77% and a return on equity of 20.66%. The firm had revenue of $15.56 billion for the quarter, compared to analyst estimates of $15.59 billion. During the same period in the prior year, the business posted $3.42 EPS. The business’s revenue for the quarter was up .2% compared to the same quarter last year. equities analysts expect that Aetna Inc will post 11.28 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, August 1st. Stockholders of record on Wednesday, July 25th were issued a $0.50 dividend. The ex-dividend date was Tuesday, July 24th. This represents a $2.00 annualized dividend and a dividend yield of 1.03%. Aetna’s dividend payout ratio is currently 20.28%.

Several analysts have recently weighed in on the stock. ValuEngine raised shares of Aetna from a “hold” rating to a “buy” rating in a research note on Tuesday, June 26th. Zacks Investment Research cut shares of Aetna from a “hold” rating to a “sell” rating in a research note on Tuesday, July 24th. Cantor Fitzgerald reissued a “buy” rating and issued a $202.00 price target on shares of Aetna in a research note on Thursday, August 2nd. Finally, Credit Suisse Group dropped their price target on shares of Aetna from $208.00 to $194.00 and set a “neutral” rating for the company in a research note on Monday, May 14th. Seven investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $200.38.

Aetna Company Profile

Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.

Featured Article: Marijuana Stocks Investing Considerations

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply